Search

Your search keyword '"anti-platelet agents"' showing total 92 results

Search Constraints

Start Over You searched for: Descriptor "anti-platelet agents" Remove constraint Descriptor: "anti-platelet agents"
92 results on '"anti-platelet agents"'

Search Results

1. Survival outcomes of patients with concomitant acute variceal bleeding and acute coronary syndrome, and the role of antiplatelet agents: an institutional experience from a lower middle-income Country

2. Sepsis -- it is all about the platelets.

3. Sepsis – it is all about the platelets

4. Survival outcomes of patients with concomitant acute variceal bleeding and acute coronary syndrome, and the role of antiplatelet agents: an institutional experience from a lower middle-income Country.

6. Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease

7. Endoscopie digestive et gestion des patients sous antithrombotiques oraux.

8. Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia

9. TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE

10. Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia.

11. Effects of Pre-Hospital Antiplatelet Therapy on the Incidence of ARDS.

12. Anti-platelet agents: past, present and future.

15. TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE.

16. Efficacy and safety of ticagrelor in patients with acute coronary syndrome: A meta‐analysis of randomized controlled trials.

17. Safety and efficacy of anti-thrombotic regimens in patients with percutaneous coronary intervention requiring oral anticoagulation: A traditional and network meta-analysis.

18. Microfludic platforms for the evaluation of anti-platelet agent efficacy under hyper-shear conditions associated with ventricular assist devices.

19. Optimal pediatric dosing of anti-platelet agents for pipeline stent embolization -a case report and review of the literature.

21. Hypoxia Modulates Platelet Purinergic Signalling Pathways

22. Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease

23. Aspirin Half Maximal Inhibitory Concentration Value on Platelet Cyclooxygenase1 in Severe Type-2 Diabetes Mellitus is not Significantly Different from that of Healthy Individuals.

24. Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence.

25. Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial

26. Clopidogrel “resistance”: Pre- vs post-receptor determinants.

27. Identification of the active region responsible for the anti-thrombotic activity of anopheline anti-platelet protein from a malaria vector mosquito.

28. Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery.

29. Antiplatelet therapy in ENT surgery: a review.

30. Anopheline anti-platelet protein from a malaria vector mosquito has anti-thrombotic effects in vivo without compromising hemostasis

31. The effects of cytochalasin D and abciximab on hemostasis in canine whole blood assessed by thromboelastography and the PFA-100® platelet function analyzer system.

32. Bleeding associated with current therapies for acute coronary syndrome: What are the mechanisms?

33. An in vitro method for screening anti-platelet agents using a microchannel array flow analyzer.

34. Patients under anti-platelet therapy.

35. Point-of-care assessment of antiplatelet agents in the perioperative period: a review.

36. Haemorrhagic stroke during anti-platelet therapy.

37. Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures.

38. Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based Experiment

39. Anticoagulant therapy, anti-platelet agents and gastrointestinal endoscopy.

40. Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based Experiment

41. Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease.

42. Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism

44. Microfludic platforms for the evaluation of anti-platelet agent efficacy under hyper-shear conditions associated with ventricular assist devices

45. Intracranial hemorrhage and platelet transfusion after administration of anti-platelets agents: Fukushima Prefecture

46. Effects of Pre-Hospital Antiplatelet Therapy on the Incidence of ARDS.

47. Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism

48. Intracranial hemorrhage and platelet transfusion after administration of anti-platelets agents: Fukushima Prefecture

49. Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect?

Catalog

Books, media, physical & digital resources